Related Experiment Videos
Elemental signals regulating eosinophil accumulation in the lung
P S Foster1, A W Mould, M Yang
1Division of Biochemistry and Molecular Biology, John Curtin School of Medical Research, Australian National University, Acton, Canberra ACT. Paul.Foster@anu.edu.au
Immunological Reviews
|April 9, 2001
Summary
Two key pathways regulate eosinophil accumulation in allergic lungs, impacting airways hyperreactivity. Targeting Interleukin-5 (IL-5) and CCR3 signaling is crucial for resolving asthma inflammation.
Area of Science:
- Immunology
- Pulmonary Medicine
- Allergy Research
Background:
- Eosinophil accumulation in allergic lung tissues contributes to airways hyperreactivity (AHR).
- Understanding the regulatory mechanisms of eosinophil trafficking is vital for asthma treatment.
Purpose of the Study:
- To identify key signaling pathways regulating eosinophil accumulation in the allergic lung.
- To elucidate the roles of Interleukin-5 (IL-5), Interleukin-4 (IL-4), Interleukin-13 (IL-13), and eotaxin in eosinophil recruitment and AHR.
Main Methods:
- Review of existing literature on eosinophil regulation in allergic lung inflammation.
- Analysis of the interplay between systemic and local factors controlling eosinophil pools.
Main Results:
- Two interwoven mechanisms control eosinophil accumulation: IL-5 expands eosinophil pools systemically, while IL-4 and IL-13 promote transmigration into lung tissue.
- IL-4 and IL-13 regulate IL-5 and eotaxin production, enhancing local eosinophil recruitment and synergizing with IL-5.
- Concurrent inhibition of IL-5 and eotaxin pathways significantly reduces pulmonary inflammation and AHR.
Conclusions:
- IL-5 acts both systemically and locally to drive eosinophilia and AHR in allergic lungs.
- IL-4 and IL-13 orchestrate tissue and peripheral eosinophil responses by modulating IL-5 and eotaxin.
- Targeting both IL-5 and CCR3 signaling pathways offers a promising strategy for managing asthma-related inflammation and AHR.